Advanced Search

LatinNews Daily - 08 February 2021

Click here for printer friendly version
Click here for full report

In brief: Brazil launches tender for region’s largest vaccine factory

* The Fundação Oswaldo Cruz (Fiocruz) scientific research institute, which is linked to Brazil’s federal government, has launched the tender process for the construction of what would be the largest vaccines and medicines factory in Latin America, the Complexo Industrial de Biotecnologia em Saúde (CIBS) which will be part of Bio Manguinhos, Fiocruz’s vaccine production arm. According to Brazil’s federal health ministry, the construction of the CIBS – which is expected to begin in the second half of 2021 and be completed within four years – will involve an investment of around R$3.4bn (US$633m) and generate 5,000 jobs during the construction stage, and 1,500 direct jobs once the plant is operational. Built on a 580,000m2 area in the Santa Cruz neighbourhood of the city of Rio de Janeiro, the CIBS complex will have the capacity to produce 120m vials of vaccines and biopharmaceuticals per year (equivalent to over 600m doses). “The health ministry is proud, alongside its Foundation, to launch the largest industrial complex in Latin America. We need to be self-sufficient in the production of active pharmaceutical ingredients, vaccines, and materials to fight the coronavirus and other viruses”, Health Minister Eduardo Pazuello said during the launch of the tender, describing the moment as a “milestone” for the country and its public health service, the SUS.